• HotStart qPCR Master Mix for hly Assays

  2026-08-15

  Learn how HotStart Universal 2X FAST Green qPCR Master Mix supports mechanistic gene expression analysis in Listeria monocytogenes. This guide connects hly deletion biology with assay design, ROX normalization, inhibition control, and melt-curve interpretation.

• Tomivosertib and Human DRG Ectopic Activity

  2026-08-14

  The reference study provides direct human evidence that MNK inhibition with tomivosertib can reversibly suppress spontaneous activity in sensory neurons obtained from patients with radiculopathy. Its combination of ex vivo human electrophysiology and rapid eIF4E target engagement strengthens the translational case for MNK inhibitors in neuropathic pain while leaving important questions about cell selectivity, dosing, and clinical efficacy unresolved.

• Catalpol Workflows for Neurovascular Unit Research

  2026-08-14

  Catalpol enables integrated neurovascular unit experiments that connect neuronal survival, vascular repair, astrocyte support, and VEGF signaling in one workflow. This guide translates ischemic stroke evidence into practical dosing, assay-selection, preparation, and troubleshooting decisions while defining where broader disease-model applications remain exploratory.

• Foretinib Workflow for Cancer Drug Response Assays

  2026-08-13

  Foretinib (GSK1363089) supports coordinated studies of tumor cell growth inhibition, HGF-driven motility, invasion, and metastasis across cancer models. This workflow pairs practical dosing guidance with separate growth and cell-death measurements, helping researchers distinguish cytostatic responses from true cytotoxicity.

• WM-8014: A Mechanistic Guide to KAT6A Inhibition

  2026-08-13

  WM-8014 is a reversible KAT6A inhibitor that connects acetyl-CoA competition with cell-cycle arrest and senescence biology. This article explains how to use its mechanism, temporal behavior, and model-specific evidence to design more informative cancer biology research assays.

• HCN4 Heat Sensing Sets Heart Rate Responses

  2026-08-12

  A 2025 Nature Communications study identifies the conserved HCN4 S4–S5 linker motif M407/Y409 as a molecular determinant of heat-sensitive pacemaker activity. Computational modeling, mutagenesis, electrophysiology, and CRISPR/Cas9 mouse models show that this motif couples temperature to HCN4 current, cAMP responsiveness, and heart-rate acceleration.

• ECL Western Blotting Substrate: Practical Guide

  2026-08-12

  ECL Western Blotting Substrate (SKU K2187) is a luminol-based horseradish peroxidase detection reagent for nonradioactive immunoblot workflows requiring chemiluminescent signal development. It is intended for HRP-based Western blot assays and should not be substituted into fluorescent or radioisotopic detection protocols.

• Annexin V-Cy5/DAPI Apoptosis Kit Workflow

  2026-08-11

  Build a rapid cell-death workflow that separates viable, early apoptotic, late apoptotic, and membrane-compromised populations in one experiment. The Annexin V-Cy5/DAPI Apoptosis Kit is especially useful for linking drug response to the mitochondrial apoptosis mechanisms reported in Ph+ ALL research.

• Azathramycin A: A Degradation-Aware Research Guide

  2026-08-10

  Explore Azathramycin A as a macrolide antibiotic for ribosome-focused tuberculosis research. This guide connects its chemical provenance, assay design, and the reference study’s component-simplification strategy to improve interpretation in mechanistic and resistance experiments.

• Phagocytic Giant Cancer Macrophages in Blood

  2026-08-09

  The reference study positions circulating cancer-associated macrophage-like cells, or CAMLs, as biologically active phagocytic polyploid giant cancer macrophages rather than passive cellular debris. In a prospective, multi-institutional cohort spanning six solid tumor types, CAML abundance and phenotype were associated with disease progression and spread, suggesting a blood-based window into metastatic niche biology.

• EZH2–AKT1–eIF4F Co-inhibition in BRAF Melanoma

  2026-08-08

  The reference study identifies coordinated ERK1/2–EZH2 and AKT1–eIF4E signaling as adaptive resistance mechanisms after eIF4F inhibition in BRAFV600E melanoma cells. Its combination data support simultaneous targeting of eIF4F, EZH2, and AKT1 as a preclinical strategy for improving responses to translation-initiation and BRAF inhibition.

• CPI-613 Workflows for Mitochondrial Cancer Studies

  2026-08-07

  CPI-613 enables mechanism-guided studies of mitochondrial carbon metabolism, apoptosis, and treatment resistance across cancer models. This workflow-centered guide shows how to connect PDH/KGDH perturbation with ATP, membrane-potential, and cell-death readouts while avoiding common dosing and interpretation errors.

• Applied Use-Cases for ABT-263 (Navitoclax) in Apoptosis Assa

  2026-08-07

  ABT-263 (Navitoclax) distinguishes itself as a benchmark BH3 mimetic for dissecting Bcl-2 family-mediated apoptosis and senescence in cancer biology. This guide delivers actionable workflows, troubleshooting strategies, and insights from the latest senotherapeutic research to enable robust, reproducible experimental outcomes.

• Mitoxantrone in Anticancer Research: Workflows and Resistanc

  2026-08-06

  Mitoxantrone's dual role as a topoisomerase II inhibitor and apoptosis inducer in B-CLL cells makes it indispensable for translational oncology and antiviral research. Recent advances, including synergistic use with ABCG2 inhibitors like marein, are transforming experimental outcomes and overcoming drug resistance bottlenecks.

• Serum Proteomics Identifies HGFA as a Biomarker for PAH

  2026-08-06

  The study by Zhang et al. applies advanced serum proteomics to uncover hepatocyte growth factor activator (HGFA) as a promising biomarker for pulmonary arterial hypertension (PAH). These findings highlight HGFA’s diagnostic potential and establish new experimental directions for early, noninvasive PAH detection.

453 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page